Drug Shortage Report for TEVA-MYCOPHENOLATE
Report ID | 96727 |
Drug Identification Number | 02348675 |
Brand name | TEVA-MYCOPHENOLATE |
Common or Proper name | MYCOPHENOLATE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | MYCOPHENOLATE MOFETIL |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 50 |
ATC code | L04AA |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-10-16 |
Estimated end date | 2020-07-31 |
Actual end date | 2020-06-25 |
Shortage status | Resolved |
Updated date | 2020-06-26 |
Company comments | Allocating to 100% of our monthly demand. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v24 | 2020-06-26 | French | Compare |
v23 | 2020-06-26 | English | Compare |
v22 | 2020-06-22 | French | Compare |
v21 | 2020-06-22 | English | Compare |
v20 | 2020-06-16 | French | Compare |
v19 | 2020-06-16 | English | Compare |
v18 | 2020-06-04 | French | Compare |
v17 | 2020-06-04 | English | Compare |
v16 | 2020-05-21 | French | Compare |
v15 | 2020-05-21 | English | Compare |
v14 | 2020-05-14 | French | Compare |
v13 | 2020-05-14 | English | Compare |
v12 | 2020-05-08 | French | Compare |
v11 | 2020-05-08 | English | Compare |
v10 | 2020-05-01 | French | Compare |
v9 | 2020-05-01 | English | Compare |
v8 | 2020-02-13 | French | Compare |
v7 | 2020-02-13 | English | Compare |
v6 | 2020-01-24 | French | Compare |
v5 | 2020-01-24 | English | Compare |